Browse 39 psoriatic arthritis clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.
Filter
1
Filter results
Results: 39
FeaturedActive & Responsive
A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
for
Juvenile Psoriatic Arthritis
Location: Valhalla NY, New York NY, Washington D.C. DC,
Sponsor: AbbVie
Sex: All
Age: 5 - 17
Code: NCT06100744
Phase3, Recruiting
Featured
Study to Evaluate Pregnancy Outcomes in Risankizumab Exposed Pregnancies Relative to Those Non-risankizumab Exposed Pregnancies in Women With FDA Approved Indications
for
Plaque Psoriasis, Psoriatic Arthritis, Crohn's Disease, or Other Conditions for Which Risankizumab is an FDA-approved Treatment,
Location: Morrisville NC
Sponsor: AbbVie
Sex: Female
Age: 0+
Code: NCT04846959
Recruiting
Active & Responsive
Creating Health Course Study for People With Rheumatological Conditions and Mood Disorders
for
Rheumatoid Arthritis, Sjogren's Syndrome,
Location: Iowa City IA
Sponsor: Terry L. Wahls
Sex: All
Age: 18 - 70+
Code: NCT07180537
Recruiting
Active & Responsive
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability up to 6 Years of Intravenous (i.v.) Secukinumab in Pediatric Participants With Juvenile Psoriatic Arthritis (JPsA).
for
Juvenile Psoriatic Arthritis
Location: New York NY, Pittsburgh PA, Charlotte NC,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 2 - 17
Code: NCT06751238
Phase1, Recruiting
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines
An Open-label Study to Evaluate the Pharmacokinetics and Safety of Bimekizumab in Pediatric Study Participants With Active Juvenile Idiopathic Arthritis Subtypes Enthesitis-related Arthritis (Including Juvenile-onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis